NCT04422366
- Conditions
- AIS, CIN1, CIN2, +45 more
- Locations
-
- Liuzhou center for disease control and prevention Liuzhou, Guangxi, China
Clinical trial condition
CIN1
Explore clinical trials studying CIN1. Study availability and eligibility vary by location and protocol.
9 public trials
3 recruiting studies
CIN1 trial results
Recruiting
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
NCT05371353
- Conditions
- CIN1, CIN2, CIN3, +36 more
- Locations
-
- Yangchun Center For Disease Prevention And Control Yangchun, Guangdong, China
- Center for Disease Control and Prevention Mianyang, Sichuan, China
NCT05027776
- Conditions
- CIN1, CIN2, CIN3, +36 more
- Locations
-
- Center for Disease Control and Prevention Mianyang, Sichuan, China
Not Yet Recruiting
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
NCT07545746
- Conditions
- Blood-Borne Infections, CIN, CIN1, +39 more
- Locations
-
- Maseno University Kisumu, Kenya
- Nyanza Reproductive Health Society Kisumu, Kenya
NCT04607850
- Conditions
- CIN1, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- UZA Antwerp, Belgium
- Erasme Hospital Brussels, Belgium
- UZ Brussel Brussels, Belgium
- UZ Gent Ghent, Belgium
NCT05372016
- Conditions
- AIS, CIN1, CIN2, +46 more
- Locations
-
- Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Guangxi, China
NCT04425291
- Conditions
- AIS, CIN1, CIN2, +45 more
- Locations
-
- Yangchun Center For Disease Prevention And Control Yangchun, Guangdong, China
NCT02405533
- Conditions
- CIN1, CIN2, Dysplasia, +1 more
- Locations
-
- UTHealth Medical School at Houston Houston, Texas, United States
NCT03676101
- Conditions
- AIS, CIN 3, CIN1, +46 more
- Locations
-
- Zhejiang Provincial Center for Disease Control and Prevention Hanzhou, China